The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Top Trump ally Steve Daines exits Montana Senate race, plans to retire
GOP senators tangle with Noem during heated hearing on her handling of deportation surge
Popular Far-Left Streamer Advises Suicide Bombers to Switch to Drones for Terror Campaigns
Perfect Justice: We’re Raining Destruction on Iran Using a Suicide Drone They Designed But We Perfected
Rep. Tony Gonzales admits to affair with staffer who died by suicide: ‘Lapse in judgment’
Five takeaways from Minnesota fraud hearing where Walz acknowledged failures
Walz mocked online after GOP lawmaker floats theory in heated hearing about why Kamala Harris chose him as VP
Fox News Poll: Voters give poor marks to economy, Congress and Trump
BREAKING: Kurds Open New Front Against Iranian Regime, Launch Major Ground Offensive
Watch: Schumer Repeatedly Struggles to Condemn Iran Strikes: ‘No One Wants a Nuclear Israel’
Starmer defends waffling on Iran: ‘Hanging on to President Trump’s latest words’ is not ‘special relationship in action’
Planning committee expecting outrage at White House ballroom meeting after 9,000 pages of negative comments
GOP begs Trump to endorse Cornyn as president teases decision ‘soon’
White House and State Department defend evacuation strategies for US citizens
Man dies after sneaking into closed section of popular national park
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Top Trump ally Steve Daines exits Montana Senate race, plans to retire
GOP senators tangle with Noem during heated hearing on her handling of deportation surge
Popular Far-Left Streamer Advises Suicide Bombers to Switch to Drones for Terror Campaigns
Perfect Justice: We’re Raining Destruction on Iran Using a Suicide Drone They Designed But We Perfected
Rep. Tony Gonzales admits to affair with staffer who died by suicide: ‘Lapse in judgment’
Five takeaways from Minnesota fraud hearing where Walz acknowledged failures
Walz mocked online after GOP lawmaker floats theory in heated hearing about why Kamala Harris chose him as VP
Fox News Poll: Voters give poor marks to economy, Congress and Trump
BREAKING: Kurds Open New Front Against Iranian Regime, Launch Major Ground Offensive
Watch: Schumer Repeatedly Struggles to Condemn Iran Strikes: ‘No One Wants a Nuclear Israel’
Starmer defends waffling on Iran: ‘Hanging on to President Trump’s latest words’ is not ‘special relationship in action’
Planning committee expecting outrage at White House ballroom meeting after 9,000 pages of negative comments
GOP begs Trump to endorse Cornyn as president teases decision ‘soon’
White House and State Department defend evacuation strategies for US citizens
Man dies after sneaking into closed section of popular national park
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
